Mycamine 50 mg
Mycamine 50 mg is a medicine authorised by Swissmedic under authorisation number 60724. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 July 2012 and the authorisation is valid without a time limit. ATC code J02AX05 places the medicine in the group Antimycotics for systemic use.
| Authorisation number | 60724 |
|---|---|
| Name | Mycamine 50 mg |
| Full name | Mycamine 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J02AX05 |
| First authorisation | 11 July 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Mycamine 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 11 July 2012 |
| 2 | Mycamine 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 11 July 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J02AX05 | 08.06.0. | A |
| 2 | 1 | Durchstechflasche(n) | J02AX05 | 08.06.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Mycamine 50 mg authorised in Switzerland?
Yes. Mycamine 50 mg is authorised by Swissmedic under authorisation number 60724, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Mycamine 50 mg have?
Mycamine 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Mycamine 50 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.